Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Convertino I, Lorenzoni V, Gini R, Turchetti G, Fini E, Giometto S, Bartolini C, Paoletti O, Ferraro S, Cappello E, Valdiserra G, Bonaso M, Blandizzi C, Tuccori M, Lucenteforte E.
Convertino I, et al. Among authors: lucenteforte e.
Pharmaceuticals (Basel). 2023 Mar 21;16(3):465. doi: 10.3390/ph16030465.
Pharmaceuticals (Basel). 2023.
PMID: 36986565
Free PMC article.